Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-09

Clinical Trial Update: Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of bimatoprost in Japanese patients with eyelash hypotrichosis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Eyelash Hypotrichosis | Phase 3 | Status: COMPLETED | Results posted: 2013-07-09